HALOA complex can alter the molecular proliferative markers (Leptin, IL-8, and MMP-9) and apoptotic markers (Survivin) of CML cells. This evidence concerns the gene CXCL8 and chronic myelogenous leukemia, BCR-ABL1 positive.